SCHEMBL850754

SCHEMBL850754

CC(CO[Si](C(C)C)(C(C)C)C(C)C)OCC(Oc1ncnc2c1cnn2-c1ccccc1Cl)C(=O)Nc1ccc(C#N)cn1

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.83
KCNH2 Q12809 16/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL840315 1.00 GCK (0.83) GCKKCNH2
SCHEMBL840314 1.00 GCK (0.83) GCKKCNH2
SCHEMBL838497 0.92 GCK (0.88) GCKKCNH2
SCHEMBL839518 0.91 GCK (1.00) GCKKCNH2
SCHEMBL837952 0.91 GCK (1.00) GCKKCNH2
SCHEMBL850078 0.90 GCK (0.83) GCKKCNH2
SCHEMBL838682 0.90 GCK (0.83) GCKKCNH2
SCHEMBL838683 0.90 GCK (0.83) GCKKCNH2
SCHEMBL840486 0.90 GCK (0.72) GCKKCNH2
SCHEMBL850086 0.90 GCK (0.72) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143263-B2 Therapeutic agents ASTRAZENECA AB (SE) 2012-03-27 US disclosed
US-20100093757-A1 THERAPEUTIC AGENTS 414 ASTRAZENECA AB (SE) 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093757-A1 THERAPEUTIC AGENTS 414 GCK, GCKR, GPR119 GCK 1/4885KCNH2 1438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.